IPV BSL-3/polio containment guidelines (Feb 2003) - World Health ...

World Health Organization (1995). Biosafety Guidelines for Personnel Engaged in the
Production of Vaccines and Biological Products for Medical Use. Geneva: World Health
Organization
World Health Organization (1999). Quality assurance of pharmaceuticals. Volume 2
Good manufacturing practices and inspection. Geneva: World Health Organization.
World Health Organization (2003). WHO global action plan for laboratory containment
of wild polioviruses, Version 2. Geneva: World Health Organization.
Recommendations for poliomyelitis vaccine (inactivated) In: WHO Expert Committee
on Biological Standardization. Fifty-first report , Geneva, World Health Organization,
2000 (Technical Report Series, 910, in press).
AUTHORS
The first draft of these guidelines was prepared by Dr Scott Lambert, WHO and
Mrs Mary Ellen Kennedy, Consultant in Biosafety, Ontario, Canada.
This draft was discussed in a consultation held in Geneva on 25 March 2002 attended by
the following people:
Dr Mehdi Perveen Ashtiani, Deputy Director Production, Razi Institute, Hessarak-
Karadaj, Iran; Dr Konstantin Chumakov, Food and Drug Administration, Laboratory of
Method Development, Center for Biologics Evaluation and Research, Rockville, USA;
44
Adopted by the 53 rd meeting of the WHO Expert Committee on Biological Standardization, 17-21 February 2003. A definitive
version of this document, which will differ from this version in editorial but not scientific detail, will be published in the WHO
Technical Report Series.